Ireneusz Fafara
Chief Executive Officer at ORLEN SPÓ?KA AKCYJNA
Profile
Ireneusz Fafara is currently the Chief Executive Officer at ORLEN SA. He is also the Chairman of the Management Board at Helix Immuno-Oncology SA and the President of 4cell Therapies SA. Previously, he served as the Chairman and Chief Executive Officer at ORLEN Lietuva AB.
He was also the Chairman of the Management Board at Bank Gospodarstwa Krajowego SA from 2007 to 2009.
Mr. Fafara has experience as an Independent Director at Helix BioPharma Corp.
He served on the Supervisory Boards of Powszechna Kasa Oszczednosci Bank Polski SA and Grupa LOTOS SA from 2009 to 2010.
Additionally, he was a Member of the Supervisory Board at National Health Fund from 2005 to 2008.
Mr. Fafara held the position of Vice President of the Management Board at the Social Insurance Institution from 1998 to 2007.
He is also a Member of the Supervisory Board at Rockbridge FIZ Bezpieczna Inwestycja 2 since 2018.
Mr. Fafara obtained his undergraduate degree from Cracow University of Economics.
Ireneusz Fafara active positions
| Companies | Position | Start |
|---|---|---|
| ORLEN SPÓ?KA AKCYJNA | Chief Executive Officer | 2024-04-10 |
Helix Immuno-Oncology SA
 Helix Immuno-Oncology SA Pharmaceuticals: MajorHealth Technology Helix Immuno-Oncology SA engages in the research and development in the area of biotechnology. It develops technology and products with applications in cancer immunotherapy. The company was founded in 2013 and is headquartered in Gliwice, Poland. | Chief Executive Officer | - |
Former positions of Ireneusz Fafara
| Companies | Position | End |
|---|---|---|
| ROCKBRIDGE FUNDUSZ INWESTYCYJNY ZAMKNIETY BEZPIECZNA INWESTYCJA 2 | Director/Board Member | 2023-12-31 |
| GRUPA LOTOS S.A. | Director/Board Member | 2009-12-31 |
| PKO BANK POLSKI S.A. | Director/Board Member | 2009-12-31 |
Bank Gospodarstwa Krajowego SA
 Bank Gospodarstwa Krajowego SA Finance/Rental/LeasingFinance Bank Gospodarstwa Krajowego SA provides state-owned bank supporting public finance activities. It also offers commercial banking and depository services and products, specializing in servicing and financing enterprises and local government entities. It also funds government projects, such as highway construction. The company was founded in 1924 and is headquartered in Warsaw, Poland. | Chief Executive Officer | 2008-12-31 |
| National Health Fund | Director/Board Member | 2007-12-31 |
Training of Ireneusz Fafara
| Cracow University of Economics | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ORLEN SPÓ?KA AKCYJNA | Energy Minerals |
| HELIX BIOPHARMA CORP. | Health Technology |
| PKO BANK POLSKI S.A. | Finance |
| Private companies | 7 |
|---|---|
ORLEN Lietuva AB
 ORLEN Lietuva AB Oil Refining/MarketingEnergy Minerals ORLEN Lietuva AB refines, markets, and distributes petroleum products. Its activities include oil refining, pipeline and marine terminal operations, marketing, and logistics of refined products. The firm markets products in the Lithuanian, Latvian, and Estonian markets through Mazeikiu Nafta Trading House. The company was founded on March 28, 1995 and is headquartered in Mazeikiai, Lithuania. | Energy Minerals |
Bank Gospodarstwa Krajowego SA
Bank Gospodarstwa Krajowego SA Finance/Rental/LeasingFinance Bank Gospodarstwa Krajowego SA provides state-owned bank supporting public finance activities. It also offers commercial banking and depository services and products, specializing in servicing and financing enterprises and local government entities. It also funds government projects, such as highway construction. The company was founded in 1924 and is headquartered in Warsaw, Poland. | Finance |
Grupa LOTOS SA
 Grupa LOTOS SA Oil Refining/MarketingEnergy Minerals Grupa Lotos SA engages in the production and process of refined petroleum products. It operates through Exploration and Production and Refining and Marketing segments. The Exploration and Production segment comprises activities related to the acquisition of crude oil and natural gas reserves, and crude oil and natural gas production. The Refining and Marketing segment includes production and processing of refined petroleum products and their wholesale and retail sale, as well as auxiliary, transport and service activities. The firm's products include unleaded petrol, diesel oil, aviation fuel, engine oils, modified bitumens, and paraffins. The company was founded on September 18, 1991 and is headquartered in Gdansk, Poland. | Energy Minerals |
| National Health Fund | |
| Social Insurance Institution | Government |
Rockbridge FIZ Bezpieczna Inwestycja 2
 Rockbridge FIZ Bezpieczna Inwestycja 2 Investment Trusts/Mutual FundsMiscellaneous Rockbridge FIZ Bezpieczna Inwestycja 2 closed-ended mutual investment fund, which engages in the investment activities with high returns and protection of the invested capital. The fund was founded in 1998 and is headquartered in Warsaw, Poland. | Miscellaneous |
Helix Immuno-Oncology SA
Helix Immuno-Oncology SA Pharmaceuticals: MajorHealth Technology Helix Immuno-Oncology SA engages in the research and development in the area of biotechnology. It develops technology and products with applications in cancer immunotherapy. The company was founded in 2013 and is headquartered in Gliwice, Poland. | Health Technology |
- Stock Market
- Insiders
- Ireneusz Fafara